Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	2,894	2,859	2,816	3,106	2,218	1,790
Other Revenue	0.68	0.68	0.57	0.99	1.07	1.49
Revenue	2,895	2,859	2,816	3,107	2,219	1,792
Revenue Growth (YoY)	-2.02%	1.52%	-9.37%	40.06%	23.83%	30.28%
Cost of Revenue	2,763	2,667	2,703	2,779	1,899	1,642
Gross Profit	131.28	191.83	113.21	328.8	319.58	149.22
Selling, General & Admin	25.87	25.35	23.62	20.51	18.37	15.77
Other Operating Expenses	63.15	62.39	64.46	67.99	57.48	40.73
Operating Expenses	95.77	94.28	94.55	94.94	81.8	63.7
Operating Income	35.51	97.54	18.66	233.86	237.78	85.52
Interest Expense	-8.23	-4.86	-5.53	-9.3	-3.64	-9.37
Interest & Investment Income	3.69	3.69	3.05	2	1.38	0.86
Currency Exchange Gain (Loss)	0.6	0.6	0.32	1.53	0.6	-
Other Non Operating Income (Expenses)	-4.58	-1.21	-1.35	-3.02	-0.18	-3.4
EBT Excluding Unusual Items	26.98	95.76	15.15	225.07	235.94	73.6
Gain (Loss) on Sale of Investments	4.05	4.05	9.87	0.23	0.08	-
Gain (Loss) on Sale of Assets	-0.95	-0.95	0.18	-	-0.23	-
Other Unusual Items	-	-	-	-	-	-0.18
Pretax Income	30.09	98.86	25.2	225.3	236.01	73.44
Income Tax Expense	14.39	27.74	3.58	59	64.16	20.11
Net Income	15.69	71.12	21.63	166.31	171.85	53.33
Net Income to Common	15.69	71.12	21.63	166.31	171.85	53.33
Net Income Growth	-75.73%	228.87%	-87.00%	-3.23%	222.22%	25.88%
Shares Outstanding (Basic)	3	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3	3
EPS (Basic)	5.08	23.02	7.00	53.83	55.62	17.26
EPS (Diluted)	5.08	23.02	7.00	53.83	55.62	17.26
EPS Growth	-75.73%	228.87%	-87.00%	-3.23%	222.25%	25.89%
Free Cash Flow	107.22	-105.99	87.45	-108.96	161.98	20.69
Free Cash Flow Per Share	34.69	-34.30	28.30	-35.27	52.42	6.70
Dividend Per Share	-	1.000	1.000	1.000	1.000	-
Gross Margin	4.54%	6.71%	4.02%	10.58%	14.40%	8.33%
Operating Margin	1.23%	3.41%	0.66%	7.53%	10.72%	4.77%
Profit Margin	0.54%	2.49%	0.77%	5.35%	7.75%	2.98%
Free Cash Flow Margin	3.70%	-3.71%	3.10%	-3.51%	7.30%	1.16%
EBITDA	42.25	104.08	25.12	240.28	243.71	90.44
EBITDA Margin	1.46%	3.64%	0.89%	7.73%	10.98%	5.05%
D&A For EBITDA	6.74	6.53	6.46	6.42	5.94	4.93
EBIT	35.51	97.54	18.66	233.86	237.78	85.52
EBIT Margin	1.23%	3.41%	0.66%	7.53%	10.72%	4.77%
Effective Tax Rate	47.83%	28.06%	14.19%	26.19%	27.19%	27.38%
Revenue as Reported	2,900	2,868	2,830	3,111	2,224	1,795
Advertising Expenses	-	3.14	1.43	1.72	0.62	0.79

Source: S&P Global Market Intelligence. Standard template. Financial Sources.